돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 562184생성일: 2026년 10월 25일

3-Methoxypropylamine → [5-({[3-(Methyloxy)propyl]amino}methyl)-2-thienyl]boronic acid

https://huagongshe.com/reaction/562184

반응식

참여 물질

역할이름HCID투입량
반응물3-MethoxypropylamineHCID 1672—
반응물5-Formyl-2-thiopheneboronic acidHCID 2773430—
반응물Sodium cyanoborohydrideHCID 5003444—
반응물5-(5-{[(2-ethylbutyl)amino]methyl}-2-thienyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamideHCID 57732621—
생성물[5-({[3-(Methyloxy)propyl]amino}methyl)-2-thienyl]boronic acidHCID 6672290640.9%

반응 단계

Following the general procedure of 5-(5-{[(2-ethylbutyl)amino]methyl}-2-thienyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide, (5-formyl-2-thienyl)boronic acid (50 mg, 0.32 mmol), [3-(methyloxy)propyl]amine (29 mg, 0.32 mmol), and NaCNBH3 (40 mg, 0.64 mmol) were reacted to give 30 mg of crude [5-({[3-(methyloxy)propyl]amino}methyl)-2-thienyl]boronic acid. The crude [5-({[3-(methyloxy)propyl]amino}methyl)-2-thienyl]boronic acid was then reacted with 5-bromo-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide (65 mg, 0.157 mmol), K2CO3 (130 mg, 0.942 mmol), and tetrakis(triphenylphosphine)palladium(0) (9 mg, 0.0079 mmol). The crude product was purified once on an Agilent MDAP using the procedure shown in preparation of 5-(5-{[(2-ethylbutyl)amino]methyl}-2-thienyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide to give 7.6 mg of the title compound (9%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08063071B2
출처 데이터셋uspto-grants-2011_11
ORD IDord-e45433e043cd4222bb0e3804f4098865
출처 메모uspto-grants-2011_11